Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

A success in Toxinology translational research in Brazil: Bridging the gap

Full text
Author(s):
Ferreira, Ana Silvia S. B. S. [1, 2, 3] ; Barraviera, Benedito [1, 3] ; Barraviera, Silvia Regina C. S. [1, 3] ; Abbade, Luciana P. F. [3, 4] ; Caramori, Carlos Antonio [1, 2, 3] ; Ferreira, Jr., Rui Seabra [1, 3]
Total Authors: 6
Affiliation:
[1] Univ Estadual Paulista UNESP, Sao Paulo State Univ, Botucatu Med Sch, Dept Trop Dis & Image Diag, BR-18610307 Sao Paulo - Brazil
[2] Univ Estadual Paulista UNESP, Botucatu Med Sch, Clin Res Unit UPECLIN, BR-18610307 Sao Paulo - Brazil
[3] Univ Estadual Paulista UNESP, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Sao Paulo - Brazil
[4] Sao Paulo State Univ, Botucatu Med Sch, Dept Dermatol & Radiotherapy, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Toxicon; v. 69, n. SI, p. 50-54, JUL 2013.
Web of Science Citations: 4
Abstract

Basic research is fundamental for discovering potential diagnostic and therapeutic tools, including drugs, vaccines and new diagnostic techniques. On this basis, diagnosis and treatment methods for many diseases have been developed. Presently, discovering new candidate molecules and testing them in animals are relatively easy tasks that require modest resources and responsibility. However, crossing the animal-to-human barrier is still a great challenge that most researchers tend to avoid. Thus, bridging this current gap between clinical and basic research must be encouraged and elucidated in training programmes for health professionals. This project clearly shows the challenges faced by a group of Brazilian researchers who, after discovering a new fibrin sealant through 20 years of painstaking basic work, insisted on having the product applied clinically. The Brazilian government has recently become aware of this challenge and has accordingly defined the product as strategic to the public health of the country. Thus, in addition to financing research and development laboratories, resources were invested in clinical trials and in the development of a virtual platform termed the Virtual System to Support Clinical Research (SAVPC); this platform imparts speed, reliability and visibility to advances in product development, fostering interactions among sponsors, physicians, students and, ultimately, the research subjects themselves. This pioneering project may become a future model for other public institutions in Brazil, principally in overcoming neglected diseases, which unfortunately continue to afflict this tropical country. (C) 2013 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 09/06280-0 - Sexual, ontogenetic and enviromental variation in the Venom of Crotalus durissus terrificus and Bothrops jararaca on Botucatu region - São Paulo State - Brazil: pharmacological, biochemical and Enzymatical characterization
Grantee:Rui Seabra Ferreira Junior
Support type: Regular Research Grants
FAPESP's process: 09/53846-9 - Recent acquisition of preparative high-performance liquid chromatograph for the purification and isolation of serine proteinases to produce fibrin sealant
Grantee:Benedito Barraviera
Support type: Multi-user Equipment Program